EUVIMEDEUVIMED entdecken
Open Access

Nephrology Provider Perceptions about Recommending Influenza and COVID-19 Vaccines: A Nationwide Survey

Guangchen Zou, Lawrence Appel, Deidra C Crews, David Dowdy, Kunihiro Matsushita, Kristin A Riekert, Bernard G Jaar, Junichi Ishigami

American Journal of Nephrology · 2025

DOI: 10.1159/000544935 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Nephrology, 2025. Verfasst von Guangchen Zou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Mercy Hospital Saint Louis, Saint Louis, Missouri, USA. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Influenza Vaccines, COVID-19, Influenza, Human. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Vaccination rates for influenza and COVID-19 remain low among people with chronic kidney disease (CKD). Nephrology care offers an opportunity to boost vaccination rates. Understanding provider perceptions can be key to developing effective intervention programs.

Methods

We conducted a nationwide survey among nephrology care providers. In a questionnaire, we assessed the providers’ agreement with potential barriers to recommending influenza and COVID-19 vaccines and perceptions of selected vaccination programs on their acceptability, appropriateness, and feasibility.

Results

Between February and June 2023, 312 providers responded to the survey. Most providers agreed that there is sufficient evidence for influenza vaccines (270/311, 86.8%) and that vaccines reduce the risk of serious complications of influenza (277/310, 89.4%). However, 40/312 (12.8%) felt that recommending influenza vaccines is less important than other issues they must address. By profession, more physicians agreed with the evidence (112/123 or 91.1% vs. 39/49 or 79.5% for NPs and 83/101 or 82.2% for RNs, p = 0.007) than nurse practitioners (NPs) or nurses (RNs). The most perceived barrier was lack of self-efficacy: 95/311 (30.5%) felt that many patients will not get vaccinated even if they recommend it. Similar responses were seen for COVID-19 vaccines. Regarding vaccination programs, 209/235 (88.9%), 197/224 (87.9%), and 183/222 (82.4%) providers considered provider reminders acceptable, appropriate, and feasible. 209/239 (87.4%), 198/226 (87.6%), and 187/224 (83.5%) did so for standing orders. Onsite/walk-in vaccinations were viewed as acceptable by 192/242 (79.3%) but less feasible (137/222 or 61.7%). Fewer than 33% of providers perceived patient incentives as acceptable, appropriate, or feasible.

Conclusions

Most nephrology care providers believe that influenza and COVID-19 vaccinations offer evidence-based benefits, with slightly higher belief among physicians compared to NPs or RNs. However, important barriers to vaccination remain. Standing orders, provider reminders, and onsite/walk-in vaccination are favorably perceived by providers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesInfluenza VaccinesCOVID-19Influenza, HumanAttitude of Health PersonnelRenal Insufficiency, ChronicNephrologyVaccinationHumansFemaleMaleSurveys and QuestionnairesSARS-CoV-2Middle AgedAdultUnited States

Stichwörter der Autor:innen

COVID-19InfluenzaProvider perceptionVaccine

Substanzen

COVID-19 VaccinesInfluenza Vaccines

Autor:innen und Institutionen

  • Department of Nephrology, Mercy Hospital Saint Louis, Saint Louis, Missouri, USA.
  • Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Division of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA, jishiga1@jhu.edu.

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Zou, G., Appel, L., Crews, D. C., Dowdy, D., Matsushita, K., Riekert, K. A., Jaar, B. G., & Ishigami, J. (2025). Nephrology Provider Perceptions about Recommending Influenza and COVID-19 Vaccines: A Nationwide Survey. American Journal of Nephrology. https://doi.org/10.1159/000544935

Vancouver

Zou G, Appel L, Crews DC, Dowdy D, Matsushita K, Riekert KA, et al. Nephrology Provider Perceptions about Recommending Influenza and COVID-19 Vaccines: A Nationwide Survey. American Journal of Nephrology. 2025. doi:10.1159/000544935

BibTeX
@article{Zou2025,
  author = {Zou, Guangchen and Appel, Lawrence and Crews, Deidra C and Dowdy, David and Matsushita, Kunihiro and Riekert, Kristin A and Jaar, Bernard G and Ishigami, Junichi},
  title = {Nephrology Provider Perceptions about Recommending Influenza and COVID-19 Vaccines: A Nationwide Survey},
  journal = {American Journal of Nephrology},
  year = {2025},
  doi = {10.1159/000544935}
}
Kostenlos starten →